Detecting traumatic brain injury using blood tests for brain cell markers
Quantification of brain-derived extracellular vesicle microRNAs in blood by a liposome-mediated CRISPR assay for traumatic brain injury detection
This study is working on a new blood test that can quickly and accurately tell how serious a traumatic brain injury (TBI) is, making it easier for doctors to help patients after an injury.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10575436 on NIH RePORTER |
What this research studies
This research focuses on improving the diagnosis of traumatic brain injury (TBI) by developing a new blood test that can quickly and accurately identify the severity of TBI. The approach utilizes a novel liposome-mediated method to isolate and analyze microRNAs from extracellular vesicles released by brain cells, which are present in the blood after an injury. By integrating the steps of isolation and detection, this method aims to provide a more efficient and reliable way to assess TBI compared to current imaging techniques and single-marker tests.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a traumatic brain injury, including those with varying degrees of severity.
Not a fit: Patients who have not suffered a traumatic brain injury or those with other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a rapid and accurate diagnostic tool for TBI, helping to identify patients at risk for long-term brain impairment.
How similar studies have performed: While the use of extracellular vesicles as biomarkers is a growing field, this specific liposome-mediated approach for TBI detection is relatively novel and has not been widely tested in clinical settings.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Hu, Tony Y. — Tulane University of Louisiana
- Study coordinator: Hu, Tony Y.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.